RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
Status:
Terminated
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study was to test a null hypothesis that a combined modality treatment of
esophageal cancer with neoadjuvant chemotherapy or chemoradiotherapy is equivalent to surgery
alone and what are the benefits from adding irradiation to chemotherapy in neoadjuvant
treatment of esophageal cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Ministry of Scientific Research and Information Technology, Poland